INARI MED INC's ticker is NARI and the CUSIP is 45332Y109. A total of 253 filers reported holding INARI MED INC in Q3 2023. The put-call ratio across all filers is 3.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $185,718,346 | +17.4% | 2,839,730 | +4.4% | 0.09% | +25.3% |
| Q2 2023 | $158,156,565 | -8.3% | 2,720,271 | -2.6% | 0.08% | -13.8% |
| Q1 2023 | $172,459,329 | +13.7% | 2,793,316 | +17.0% | 0.09% | +10.1% |
| Q4 2022 | $151,692,169 | -8.0% | 2,386,598 | +5.2% | 0.08% | -12.2% |
| Q3 2022 | $164,819,000 | +33.4% | 2,268,976 | +24.8% | 0.09% | +47.5% |
| Q2 2022 | $123,564,000 | -24.3% | 1,817,378 | +1.0% | 0.06% | -6.2% |
| Q1 2022 | $163,126,000 | +0.6% | 1,799,717 | +1.3% | 0.06% | +10.2% |
| Q4 2021 | $162,203,000 | +70.3% | 1,777,168 | +51.4% | 0.06% | +63.9% |
| Q3 2021 | $95,220,000 | -25.9% | 1,174,099 | -14.8% | 0.04% | -26.5% |
| Q2 2021 | $128,487,000 | -9.6% | 1,377,427 | +3.7% | 0.05% | -15.5% |
| Q1 2021 | $142,105,000 | +45.1% | 1,328,081 | +18.4% | 0.06% | +41.5% |
| Q4 2020 | $97,921,000 | +85.1% | 1,121,793 | +46.3% | 0.04% | +57.7% |
| Q3 2020 | $52,910,000 | +214.1% | 766,593 | +144.5% | 0.03% | +188.9% |
| Q2 2020 | $16,843,000 | – | 313,539 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darsana Capital Partners LP | 1,475,000 | $137,588,000 | 3.91% |
| Affinity Asset Advisors, LLC | 85,000 | $7,929,000 | 2.84% |
| Parian Global Management LP | 49,800 | $4,645,000 | 1.99% |
| AlpInvest Partners B.V. | 27,960 | $2,608,000 | 1.28% |
| Sio Capital Management, LLC | 46,332 | $4,322,000 | 1.07% |
| HARBOURVEST PARTNERS LLC | 88,598 | $8,264,000 | 0.79% |
| HAMILTON LANE ADVISORS LLC | 26,403 | $2,463,000 | 0.77% |
| Pier Capital, LLC | 76,708 | $7,155,000 | 0.72% |
| Lisanti Capital Growth, LLC | 46,035 | $4,294,000 | 0.53% |
| NEXT CENTURY GROWTH INVESTORS LLC | 66,822 | $6,233,000 | 0.49% |